Compare GPK & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPK | INSP |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.2B |
| IPO Year | 2007 | 2018 |
| Metric | GPK | INSP |
|---|---|---|
| Price | $10.87 | $61.21 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 18 |
| Target Price | $12.10 | ★ $69.63 |
| AVG Volume (30 Days) | ★ 8.1M | 595.0K |
| Earning Date | 11-03-2026 | 11-02-2026 |
| Dividend Yield | ★ 4.08% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $8,617,000,000.00 | $82,050,000.00 |
| Revenue This Year | $0.33 | N/A |
| Revenue Next Year | $1.91 | $2.61 |
| P/E Ratio | $1,079.50 | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $8.15 | $38.91 |
| 52 Week High | $16.61 | $147.03 |
| Indicator | GPK | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 61.67 | 36.71 |
| Support Level | $10.09 | $60.10 |
| Resistance Level | $11.31 | $63.20 |
| Average True Range (ATR) | 0.46 | 2.72 |
| MACD | 0.13 | -0.86 |
| Stochastic Oscillator | 67.39 | 9.14 |
Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Americas Paperboard Packaging, and International Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company operates in Americas, Europe and Asia Pacific regions.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.